News & Videos - GlobeNewsWire

Innofactor Plc Stock exchange release September 7, 2024, at 22:00 (EEST) Innofactor Plc has on September 7, 2024, received a notification from Onni Bidco under Chapter 9, Section 5 of the Finnish Securities Markets Act, according to which Onni Bidco Oy's total holding, including holding through financial instruments, in Innofactor's shares increased above the 50 percent threshold. Total positions of Onni Bidco Oy according to the notification: % of shares and voting rights % of shares and voting...

NOTICE OF ANNUAL GENERAL MEETING 2024 When : 30 September 2024 at 5.00 p.m. (Malaysian Time) Where : Suite 2B-25-2, 25th Floor, Block 2B, Plaza Sentral, Jalan Stesen 5, 50470 Kuala Lumpur, Malaysia THIS DOCUMENT IS IMPORTANT AND REQUIRES YOUR IMMEDIATE ATTENTION If you are in any doubt as to the action you should take, you are recommended to seek your own personal financial advice immediately from your stockbroker, bank manager, solicitor, accountant, fund manager or other appropriate...

Press release Convening of Atos shareholders and creditors gathered in classes of affected parties to vote on the draft accelerated safeguard plan Availability of the draft accelerated safeguard plan Paris, France - September 6, 2024. Convening of the classes of affected parties By judgment of July 23, 2024, the Specialized Commercial Court of Nanterre opened an accelerated safeguard proceedings for the benefit of Atos SE (the “ Company ”), for an initial period of two months, which may be...

CALGARY, Alberta, Sept. 06, 2024 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. (" XORTX " or the “ Company ”) (NASDAQ: XRTX | TSXV: XRTX | Frankfurt: ANU), a late-stage clinical pharmaceutical company focused on developing innovative therapies to treat progressive kidney disease, reminds shareholders of the upcoming deadline to vote at the Company’s Annual General and Special Meeting (the "Meeting"), which is scheduled to be held on September 12, 2024. The Board of Directors of XORTX...

GUELPH, Ontario, Sept. 06, 2024 (GLOBE NEWSWIRE) -- (TSX: HPS.A) The Board of Directors of Hammond Power Solutions Inc. (“HPS”) declared a quarterly cash dividend of twenty-seven and a half cents ($0.275) per Class A Subordinate Voting Share of HPS and a quarterly cash dividend of twenty-seven and a half cents ($0.275) per Class B Common Share of HPS payable on September 27, 2024, to shareholders of record at the close of business on September 20, 2024. The ex-dividend date is September 20,...

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES (Note: All dollar amounts in this news release are expressed in U.S. dollars, except as otherwise noted). TORONTO, Sept. 06, 2024 (GLOBE NEWSWIRE) -- Fairfax India Holdings Corporation (“Fairfax India” or the “Company”) (TSX: FIH.U) announces that, through its wholly-owned subsidiary, it has entered into an agreement to invest INR 6,955 million (approximately $83 million at current exchange rates)...

NAARDEN, the Netherlands and MIAMI, Sept. 06, 2024 (GLOBE NEWSWIRE) -- NewAmsterdam Pharma Company N.V. (Nasdaq: NAMS or “NewAmsterdam” or the “Company”), a late-stage, clinical biopharmaceutical company developing oral, non-statin medicines for patients at risk of cardiovascular disease (“CVD”) with elevated low-density lipoprotein cholesterol (“LDL-C”), for whom existing therapies are not sufficiently effective or well-tolerated, today announced that the Compensation Committee...

DUBLIN, Ireland and CHICAGO, Sept. 06, 2024 (GLOBE NEWSWIRE) -- Iterum Therapeutics plc (Nasdaq: ITRM) (Iterum), a clinical-stage pharmaceutical company focused on developing next-generation oral antibiotics to treat infections caused by multi-drug resistant pathogens in community settings, today announced that Corey Fishman, Iterum's Chief Executive Officer, will present and host investor meetings at the 26th Annual H.C. Wainwright Global Investment Conference held September 9 to September 11,...

TORONTO, Sept. 06, 2024 (GLOBE NEWSWIRE) -- NEO Battery Materials Ltd. ( T S X V : NBM ) ( OTC: NBMFF ), a low-cost silicon anode materials developer that enables longer-running, rapid-charging lithium-ion batteries, has closed the Share Purchase Agreement (the “ Transaction ”) of NBM Korea Co., Ltd., (“ NBM Korea ”) with Automobile & PCB Inc. (“ A&P ”) pursuant to TSX Venture Exchange (the “ Exchange ”) Policy 5.3 – Acquisitions and Dispositions of Non-Cash Assets (“ Policy...

SOUTH SAN FRANCISCO, Calif. and SAN DIEGO, Sept. 06, 2024 (GLOBE NEWSWIRE) -- ORIC Pharmaceuticals, Inc. (Nasdaq:ORIC), a clinical stage oncology company focused on developing treatments that address mechanisms of therapeutic resistance, today announced that on September 3, 2024 (the “Grant Date”), ORIC granted a total of 173,200 non-qualified stock options and 28,900 restricted stock units to three new non-executive employees who began their employment with ORIC in August 2024. These...

Company Thanks Stakeholders and Employees for a Year of Remarkable Growth and Accomplishment SILVER SPRING, Md., Sept. 06, 2024 (GLOBE NEWSWIRE) -- Elutia Inc. (Nasdaq: ELUT) (“Elutia”), a pioneer in drug-eluting biomatrix products, is celebrating its one-year anniversary and the team that made it possible. On September 6, 2023, as part of a strategic shift toward drug-eluting biologics, the company rebranded as Elutia Inc. and established the mission of “Humanizing Medicine so Patients...

SAN CARLOS, Calif., Sept. 06, 2024 (GLOBE NEWSWIRE) -- Vaxcyte, Inc. (Nasdaq: PCVX), a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases, announced today the closing of its previously announced underwritten public offering of 12,087,378 shares of common stock at a public offering price of $103.00 per share and pre-funded warrants to purchase 2,427,184 shares of common stock at a public offering price of...

KING OF PRUSSIA, Pa., Sept. 06, 2024 (GLOBE NEWSWIRE) -- Vertex, Inc. (NASDAQ:VERX), a global provider of tax technology solutions, today announced that David DeStefano, Chief Executive Officer, and John Schwab, Chief Financial Officer, will participate in a fireside chat at the Goldman Sachs Communacopia + Technology Conference on Monday, September 9, 2024 at 9:30 AM Pacific Time. Live webcasts and replays of both presentations will be available on Vertex’s investor relations website at...

Interim data to be reported for RLY-2608 600mg BID + fulvestrant in 2L+, CDK4/6-experienced patients with PI3Kα-mutated, HR+/HER2- metastatic breast cancer Conference call to be held Monday, September 9, at 8am ET CAMBRIDGE, Mass., Sept. 06, 2024 (GLOBE NEWSWIRE) -- Relay Therapeutics, Inc. (Nasdaq: RLAY), a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies, today announced plans to host a...

GERMANTOWN, Md., Sept. 06, 2024 (GLOBE NEWSWIRE) -- Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucose monitoring (CGM) systems for people with diabetes, today announced plans to participate in the upcoming H.C. Wainwright 26 th Annual Global Investment Conference, being held in New York, NY. Management is scheduled to participate in the H.C. Wainwright 26 th Annual Global...

TORONTO and HAIFA, Israel, Sept. 06, 2024 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX), (OTCQB: NRXBF), (Germany: J90) (the “ Company ” or “ NurExone ”) is pleased to announce compelling new findings that highlight the therapeutic potential of ExoPTEN for patients with spinal cord injuries. In a recent preclinical study using a spinal cord compression model, our team demonstrated that ExoPTEN has a strong ability to target and accumulate at the injury site, even when...

NEW HAVEN, Conn., Sept. 06, 2024 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO) announces the Company’s repricing of a portion of its employee stock options to ensure their effectiveness as a retention tool for valuable employees. Management is confident that the practical, strategic, and economic benefit to shareholders will ultimately be positive. Retaining valuable employees in an extremely competitive industry is key to ensuring the company’s...

Reference is made to the announcement by Ensurge Micropower ASA (the "Company") on 2 September 2024, and the corrected announcement by the Company on 4 September 2024, regarding exercise of 16,000 vested incentive subscription rights under the Company's 2022 Subscription Rights Plan and the resulting issuance of a total of 16,000 new shares in the Company, and the issuance of a total of 2,216,074 shares resolved in connection with the Company's 2024 Employee Share Purchase Plan. The share...

ABC arbitrage - Communiqué d’information relatif au paragraphe 4.1 des comptes consolidés inclus dans le rapport financier annuel 2023 Conformément à l’article 17 du règlement MAR autour de la notion d’information privilégiée et bien que l’impact financier brut pour le premier semestre 2024 soit estimé à seulement 230 K€, ABC arbitrage annonce que la société Quartys Limited (filiale détenue à 100%) a reçu, en date du 30 août 2024, un courrier de refus de remboursement de...

Transaction in Own Shares 06 September, 2024 • • • • • • • • • • • • • • • • Shell plc (the ‘Company’) announces that on 06 September 2024 it purchased the following number of Shares for cancellation. Aggregated information on Shares purchased according to trading venue: Date of purchase Number of Shares purchased Highest price paid Lowest price paid Volume weighted average price paid per share Venue Currency 06/09/2024 855,000 £25.5900 £25.2150 £25.3985...